FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...
While Canada has made progress in decreasing overall breast cancer mortality, disparities remain for Black women. Research ...
Why exercise alone isn't enough for heart health Home Blood Pressure Measurement Instructions Family-Centered Care: The “Heart” of addressing genetic heart disease The best advice for women? Listen to ...
Why are people so hesitant to call an ambulance?
A practical, clinician-focused guide to interpreting high-risk PHQ-9 results, assessing suicide risk, and responding with ...
The question of whether prehospital emergency anaesthesia and intubation improves survival in patients with major trauma has ...
Introduction Dyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure.